Martin Gargiule

Martin Gargiule is a seasoned finance executive with extensive experience in various leadership roles across multiple organizations. Currently serving as VP Finance & Corporate Controller at Spectrum Vascular, Martin has held prominent positions such as Member of the Board of Directors at Scienture Inc. and Consultant - Interim Controller at Armas Pharmaceuticals. Previous roles include Chief Financial Officer at Douglas Electrical Components, VP of Finance at Advantice Health, and VP Finance – Financial Planning & Analysis at Amneal Pharmaceuticals. Martin’s career also encompasses significant financial positions at G&W Laboratories, Sandoz, Mylan Pharmaceuticals, and Deloitte, where Martin demonstrated expertise in accounting, financial reporting, and strategic planning. Martin holds a Bachelor of Science in Accounting and a Bachelor of Arts in Business Administration from Slippery Rock University of Pennsylvania.